Filing Details
- Accession Number:
- 0001203311-16-000102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-25 19:04:11
- Reporting Period:
- 2016-05-23
- Filing Date:
- 2016-05-25
- Accepted Time:
- 2016-05-25 19:04:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-05-23 | 6,700 | $10.20 | 562,815 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-05-23 | 6,700 | $40.12 | 556,115 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-05-24 | 1,700 | $10.20 | 557,815 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-05-24 | 1,700 | $40.00 | 556,115 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-05-23 | 6,700 | $0.00 | 6,700 | $10.20 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-05-24 | 1,700 | $0.00 | 1,700 | $10.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 57,169 | 2017-05-25 | No | 4 | M | Direct | |
| 55,469 | 2017-05-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 27,945 | Indirect | by Trust |
Footnotes
- Amount of securities beneficially owned following the reported transaction(s) include Restricted Stock Units that are subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
- Shares vested at a rate of 25% on 5/25/08 and monthly thereafter until all the shares were fully vested on 5/25/11.
Billionaire Hedge Funds
